Skip to main content
Top
Published in: Clinical and Translational Oncology 6/2001

01-11-2001 | Originales

Cisplatino y vinorelbina en pacientes con cáncer de ovario epitelial como tratamiento de primera línea. Estudio piloto

Authors: Germán Calderillo Ruiz, Alfonso Dueñas-González, Carlos M. López Graniel, Leticia Oliveros Herrera, Elizabeth Trejo Durán, Abelardo Meneses García, Mauricio Frías Mendivil, Jaime G. de la Garza Salazar, Dolores Gallardo Rincón

Published in: Clinical and Translational Oncology | Issue 6/2001

Login to get access
Metadata
Title
Cisplatino y vinorelbina en pacientes con cáncer de ovario epitelial como tratamiento de primera línea. Estudio piloto
Authors
Germán Calderillo Ruiz
Alfonso Dueñas-González
Carlos M. López Graniel
Leticia Oliveros Herrera
Elizabeth Trejo Durán
Abelardo Meneses García
Mauricio Frías Mendivil
Jaime G. de la Garza Salazar
Dolores Gallardo Rincón
Publication date
01-11-2001
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 6/2001
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/BF02718423

Other articles of this Issue 6/2001

Clinical and Translational Oncology 6/2001 Go to the issue

Announcement

Información

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine